Details for Patent: 10,016,415
✉ Email this page to a colleague
Which drugs does patent 10,016,415 protect, and when does it expire?
Patent 10,016,415 protects ARISTADA INITIO KIT and is included in one NDA.
This patent has forty-four patent family members in twenty-two countries.
Summary for Patent: 10,016,415
Title: | Aripiprazole prodrug compositions |
Abstract: | Described is a composition comprising (a) a population of particles of an aripiprazole prodrug having a volume based particle size (Dv50) of less than 1000 nm and (b) at least one surface stabilizer comprising an adsorbed component which is adsorbed on the surface of the aripiprazole prodrug particles and a free component available for solubilization of the aripiprazole prodrug. The surface stabilizer to prodrug ratio provides the optimal quantity of free surface stabilizer for the purposes of producing a lead-in formulation. Also described are methods of treatment using the aforementioned composition. |
Inventor(s): | Cresswell; Philip (Athlone, IE), Paquette; Sara Montminy (Hudson, MA), Hickey; Magali (Westwood, MA), Perkin; Kristopher (Athlone, IE), Smith; Greg (Norton, MA), Liversidge; Elaine (Charlestown, MA), Steinberg; Brian (Arlington, MA), Manser; David (Keenagh, IE), Turncliff; Ryan (Ashland, MA), Palmieri, Jr.; Michael (Hopkinton, MA), Zeidan; Tarek (Waltham, MA), Cash; Ethan P. (Sudbury, MA), Hard; Marjie L. (Lexington, MA) |
Assignee: | ALKERMES PHARMA IRELAND LIMITED (Dublin, IE) |
Application Number: | 14/828,229 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 10,016,415
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alkermes Inc | ARISTADA INITIO KIT | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 209830-001 | Jun 29, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,016,415
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2015306198 | ⤷ Try a Trial | |||
Brazil | 112017002926 | ⤷ Try a Trial | |||
Canada | 2957762 | ⤷ Try a Trial | |||
China | 106794251 | ⤷ Try a Trial | |||
China | 112494492 | ⤷ Try a Trial | |||
China | 112641785 | ⤷ Try a Trial | |||
Cyprus | 1121594 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |